This video will discuss the role of model-informed drug development as applied to COVID-19. It will include commentary on applying viral cell cycle models, epidemiological models, health economic models to guide treatment considerations. It will also include PK/PD considerations, the application of physiologically-based pharmacokinetic modeling, model-based meta-analyses, and how insights derived from model-based methods can inform clinical trial design, individual and combination treatments, and regimen selection for COVID-19.
